- abnormal mammary gland development / MGI
- abnormal ovarian folliculogenesis / MGI
- abnormal ovarian follicle morphology / MGI
- absent mature ovarian follicles / MGI
- absent corpus luteum / MGI
- abnormal vagina epithelium morphology / MGI
- decreased body weight / MGI
- increased incidence of induced tumors / MGI
- ovary atrophy / MGI
- uterus atrophy / MGI
- reproductive system phenotype / MGI
- adrenal gland hyperplasia / MGI
- absent nipple / MGI
- increased mammary gland tumor incidence / MGI
- mammary gland hyperplasia / MGI
- anemia / MGI
- premature death / MGI
- increased intestinal adenoma incidence / MGI
- increased intestinal adenocarcinoma incidence / MGI
- abnormal pregnancy / MGI
- extended life span / MGI
- aneuploidy / MGI
- increased incidence of tumors by chemical induction / MGI
- decreased intestinal adenoma incidence / MGI
- decreased hematocrit / MGI
- hyperlipidemia / MGI
- melena / MGI
- rectal prolapse / MGI
- abnormal intestinal mucosa morphology / MGI
- increased mammary adenocarcinoma incidence / MGI
- intestinal obstruction / MGI
- abnormal intestinal goblet cell morphology / MGI
- abnormal large intestine crypts of Lieberkuhn morphology / MGI
- intestine polyps / MGI
- abnormal enterocyte proliferation / MGI
- decreased T cell number / MGI
- decreased NK cell number / MGI
- decreased splenocyte number / MGI
- neoplasm / MGI
- increased circulating triglyceride level / MGI
- increased circulating free fatty acid level / MGI
- postnatal growth retardation / MGI
- increased colonic adenoma incidence / MGI
- hepatic steatosis / MGI
- decreased macrophage cell number / MGI
- increased prostaglandin level / MGI
- abnormal embryo development / MGI
- abnormal embryo size / MGI
- abnormal egg cylinder morphology / MGI
- abnormal cell physiology / MGI
- embryonic lethality, complete penetrance / MGI
- decreased embryo size / MGI
- embryonic lethality between implantation and placentation / MGI
- absent mandible / MGI
- abnormal brain development / MGI
- acrania / MGI
- perinatal lethality, complete penetrance / MGI
- lethality throughout fetal growth and development, incomplete penetrance / MGI
- absent midbrain / MGI
- absent forebrain / MGI
C57BL/6J-ApcMin/2H
Status | Available to order |
EMMA ID | EM:01715 |
International strain name | C57BL/6J-ApcMin/2H |
Alternative name | Apc |
Strain type | Induced Mutant Strains : Chemically-induced |
Allele/Transgene symbol | ApcMin, |
Gene/Transgene symbol | Apc |
Information from provider
Provider | Michelle Ellender |
Provider affiliation | Health Protection Agency, Chilton, Didcot, Oxon OX11 0RQ |
Genetic information | Intestinal polyposis (low multiplicity). The mutation is on chromosome 18 and is a transversion point mutation that alters nucleotide 2549 from a T to an A (mRNA: NM_001360980.1; protein: NM_007462.3). This converts codon 850 from one encoding a leucine to a stop codon (p.Leu850*), truncating the expected polypeptide. The Apc mutation is the homologue of the human APC (adenomatous polyposis coli) gene and the Min (multiple intestinal neoplasia) mice are highly susceptible to spontaneous intestinal tumour formation. This line (#2 or II) is distinct from the other ApcMin line (#5 or V) also submitted to EMMA (strain ID EM:01724). These different ApcMin lines have been described as having different severity of phenotype (Haines J et al., PNAS, 2005, doi: 10.1073/pnas.0500039102). |
Phenotypic information | Resistance to intestinal tumours. |
References |
|
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
MGI allele-associated human disease models
Orphanet associated rare diseases, based on orthologous gene matching
- Desmoid tumor / Orphanet_873
- Cenani-Lenz syndrome / Orphanet_3258
- Turcot syndrome with polyposis / Orphanet_99818
- Gastric adenocarcinoma and proximal polyposis of the stomach / Orphanet_314022
- Gardner syndrome / Orphanet_79665
- APC-related attenuated familial adenomatous polyposis / Orphanet_247806
MGI phenotypes (allele matching)
Literature references
- A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.;Moser A R, Pitot H C, Dove W F, ;1990;Science (New York, N.Y.);247;322-4; 2296722
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).